20 November 2024
Augmentum Fintech plc
Notice of Interim Results
Augmentum Fintech plc (LSE: AUGM) (the "Company" or "Augmentum"), Europe's leading publicly listed fintech fund, will announce its interim results for the six month period to 30 September 2024 on 26 November 2024.
Analyst Call
The Manager will host a conference call for analysts at 10:00 a.m. on 26 November 2024.
To register to join the call please email: results@augmentum.vc
Investor Meet Company Presentation
The Company will host an online investor presentation at 10.30 a.m. on 29 November 2024 where the Manager will present the Company's financial results for the six-month period to 30 September 2024.
The presentation will be hosted on the Investor Meet Company platform and is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00 a.m. the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and should "add to meet Augmentum Fintech plc" in order to register for the call at the following link:
https://www.investormeetcompany.com/augmentum-fintech-plc/register-investor Those who already follow Augmentum Fintech plc on the Investor Meet Company platform will automatically be invited.
Enquiries
Augmentum Fintech Tim Levene (Portfolio Manager) Georgie Hazell Kivell (Investor Relations) |
+44 (0)20 3961 5420 |
Quill PR Nick Croysdill, Sarah Gibbons-Cook (Press and Media) |
+44 (0)7815 823412
|
Peel Hunt LLP Liz Yong, Huw Jeremy (Investment Banking) |
+44 (0)20 7418 8900 |
Singer Capital Markets James Moat, James Fischer (Investment Banking) |
+44 (0)20 7496 3000 |
Frostrow Capital LLP Paul Griggs (Company Secretary) |
+44 (0)20 3709 8733 |
About Augmentum Fintech
Augmentum invests in fast growing fintech businesses that are disrupting the financial services sector. Augmentum is the UK's only publicly listed investment company focusing on the fintech sector in the UK and wider Europe, having launched on the main market of the London Stock Exchange in 2018, giving businesses access to patient capital and support, unrestricted by conventional fund timelines and giving public markets investors access to a largely privately held investment sector during its main period of growth.